Yesterday, the cofounders of Stripe published a podcast with the CEO of Eli Lilly, Dave Ricks. It’s over 2 hours in length and a great listen for a number of reasons, but one part of the interview really stood out to me as a key piece of information regarding the future of Eli Lilly’s GLP-1 […]

